Acumen Pharmaceuticals, Inc. SEC filings ABOS

Acumen Pharmaceuticals, Inc. has 365 filings in SEC EDGAR's recent list, going back to May 15, 2013. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 26, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, exit or restructuring costs). The company's fiscal year ends on December 31.

Acumen Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 10, 2026 Jun 9, 2026
144 Notice of proposed sale Jun 9, 2026 —
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2026 —
4 Insider transaction Mar 18, 2026 Mar 16, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 17, 2026 —
4 Insider transaction Mar 10, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Jan 28, 2026 Jan 26, 2026
144 Notice of proposed sale Jan 28, 2026 —
144 Notice of proposed sale Jan 26, 2026 —
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
4 Insider transaction Jan 23, 2026 Jan 21, 2026
144 Notice of proposed sale Jan 23, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
4 Insider transaction Jan 21, 2026 Jan 20, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 21, 2026 Jan 16, 2026
144 Notice of proposed sale Jan 21, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
144 Notice of proposed sale Jan 21, 2026 —
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
144 Notice of proposed sale Jan 12, 2026 —
144 Notice of proposed sale Jan 12, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 7, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 6, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
3 Initial insider ownership Nov 10, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 4, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 31, 2025 —
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
144 Notice of proposed sale Jan 23, 2025 —
144 Notice of proposed sale Jan 21, 2025 —
144 Notice of proposed sale Jan 21, 2025 —
144 Notice of proposed sale Jan 21, 2025 —
144 Notice of proposed sale Jan 21, 2025 —
144 Notice of proposed sale Jan 21, 2025 —
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
144 Notice of proposed sale Jan 3, 2025 —
144 Notice of proposed sale Jan 3, 2025 —
144 Notice of proposed sale Jan 3, 2025 —
144 Notice of proposed sale Jan 3, 2025 —
144 Notice of proposed sale Jan 3, 2025 —
4 Insider transaction Nov 6, 2024 Nov 5, 2024
3 Initial insider ownership Nov 6, 2024 Nov 5, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 10, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 6, 2024 —
4 Insider transaction Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 24, 2024 —
4 Insider transaction Jan 19, 2024 Jan 19, 2024
4 Insider transaction Jan 19, 2024 Jan 19, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
144 Notice of proposed sale Jan 19, 2024 —
144 Notice of proposed sale Jan 19, 2024 —
144 Notice of proposed sale Jan 18, 2024 —
144 Notice of proposed sale Jan 18, 2024 —
144 Notice of proposed sale Jan 18, 2024 —
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Aug 18, 2023 Aug 17, 2023
144 Notice of proposed sale Aug 17, 2023 —
SC 13D/A Amended ownership over 5% (active) Jul 25, 2023 —
4 Insider transaction Jul 25, 2023 Jul 21, 2023
4 Insider transaction Jun 13, 2023 Jun 6, 2023
4 Insider transaction Jun 7, 2023 Jun 6, 2023
4 Insider transaction Jun 7, 2023 Jun 6, 2023
4 Insider transaction Jun 7, 2023 Jun 6, 2023
4 Insider transaction Jun 7, 2023 Jun 6, 2023
4 Insider transaction Jun 7, 2023 Jun 6, 2023
4 Insider transaction Jun 7, 2023 Jun 6, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
4 Insider transaction Jan 18, 2023 Jan 17, 2023
4 Insider transaction Jan 18, 2023 Jan 17, 2023
4 Insider transaction Jan 18, 2023 Jan 17, 2023
4 Insider transaction Jan 18, 2023 Jan 17, 2023
4 Insider transaction Jan 18, 2023 Jan 17, 2023
4 Insider transaction Jan 4, 2023 Jan 4, 2023
3 Initial insider ownership Jan 4, 2023 Jan 4, 2023
4 Insider transaction Jan 3, 2023 Dec 29, 2022
SC 13G/A Amended ownership over 5% (passive) Oct 7, 2022 —
4 Insider transaction Sep 7, 2022 Sep 6, 2022
3 Initial insider ownership Sep 7, 2022 Sep 6, 2022
4 Insider transaction Jun 21, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Apr 4, 2022 Apr 1, 2022
3 Initial insider ownership Apr 4, 2022 Apr 1, 2022
SC 13G Ownership over 5% (passive) Feb 16, 2022 —
SC 13G Ownership over 5% (passive) Feb 15, 2022 —
SC 13G Ownership over 5% (passive) Feb 14, 2022 —
SC 13G Ownership over 5% (passive) Feb 4, 2022 —
SC 13G Ownership over 5% (passive) Jan 27, 2022 —
4 Insider transaction Jan 21, 2022 Jan 19, 2022
4 Insider transaction Jan 21, 2022 Jan 19, 2022
4 Insider transaction Jan 21, 2022 Jan 19, 2022
4 Insider transaction Jan 21, 2022 Jan 19, 2022
4 Insider transaction Dec 2, 2021 Nov 30, 2021
SC 13D/A Amended ownership over 5% (active) Sep 13, 2021 —
SC 13D Ownership over 5% (active) Jul 16, 2021 —
SC 13G Ownership over 5% (passive) Jul 13, 2021 —
4 Insider transaction Jul 8, 2021 Jul 6, 2021
4 Insider transaction Jul 8, 2021 Jul 6, 2021
4 Insider transaction Jul 8, 2021 Jul 6, 2021
4 Insider transaction Jul 8, 2021 Jul 6, 2021
4 Insider transaction Jul 8, 2021 Jul 6, 2021
4 Insider transaction Jul 8, 2021 Jul 6, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ABOS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Newton, MA
SEC filer status
, Emerging growth company
SEC CIK
1576885

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.